NCT04444622 - Immunotherapy for Third Line Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

Metastatic Colorectal Cancer

Interventions

BIOLOGICAL

AlloStim

Living bioengineered, non-genetically manipulated, activated Th1-like immune cells differentiated and expanded from precursor cells purified from blood of healthy unrelated donors

Trial Locations (4)

10469

Hirschfield Oncology Center, The Bronx

33140

Mt. Sinai Comprehensive Cancer Center, Miami Beach

48201

Karmanos Cancer Institute, Detroit

07932

Summit Health, Florham Park